Nasin nasal spray

Nasin is a well-established Swedish brand for nasal decongestants containing oxymetazoline. It has been a staple in Swedish pharmacies for decades, helping to relieve nasal congestion caused by the common cold or hay fever.

Originally developed and marketed by Astra (which later became AstraZeneca), the brand underwent several ownership changes during the consolidation of the pharmaceutical industry. Today, Nasin is part of the Kenvue portfolio. Kenvue was formerly the Consumer Health division of Johnson & Johnson before becoming an independent company in 2023. This product is primarily produced in Sweden, maintaining its connection to its country of origin.